75 related articles for article (PubMed ID: 22207955)
1. [Signal transduction pathways involved in progression to androgen-independent prostate cancer].
Inoue T
Nihon Rinsho; 2011 Jun; 69 Suppl 5():121-5. PubMed ID: 22207955
[No Abstract] [Full Text] [Related]
2. What controls PTEN and what it controls (in prostate cancer).
Ghosh PM
Asian J Androl; 2012 Jan; 14(1):130-1. PubMed ID: 21946231
[No Abstract] [Full Text] [Related]
3. Mechanisms underlying the development of androgen-independent prostate cancer.
Pienta KJ; Bradley D
Clin Cancer Res; 2006 Mar; 12(6):1665-71. PubMed ID: 16551847
[No Abstract] [Full Text] [Related]
4. Interleukin-8 signaling promotes translational regulation of cyclin D in androgen-independent prostate cancer cells.
MacManus CF; Pettigrew J; Seaton A; Wilson C; Maxwell PJ; Berlingeri S; Purcell C; McGurk M; Johnston PG; Waugh DJ
Mol Cancer Res; 2007 Jul; 5(7):737-48. PubMed ID: 17606477
[TBL] [Abstract][Full Text] [Related]
5. Regulation of androgen receptor signaling in prostate cancer.
Dehm SM; Tindall DJ
Expert Rev Anticancer Ther; 2005 Feb; 5(1):63-74. PubMed ID: 15757439
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction in prostate cancer progression.
Gioeli D
Clin Sci (Lond); 2005 Apr; 108(4):293-308. PubMed ID: 15603554
[TBL] [Abstract][Full Text] [Related]
7. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF
Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372
[TBL] [Abstract][Full Text] [Related]
8. Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.
Griffiths K; Morton MS; Nicholson RI
Eur Urol; 1997; 32 Suppl 3():24-40. PubMed ID: 9267783
[TBL] [Abstract][Full Text] [Related]
9. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins.
Xu Y; Chen SY; Ross KN; Balk SP
Cancer Res; 2006 Aug; 66(15):7783-92. PubMed ID: 16885382
[TBL] [Abstract][Full Text] [Related]
10. Guanosine phosphate binding protein coupled receptors in prostate cancer: a review.
Raj GV; Barki-Harrington L; Kue PF; Daaka Y
J Urol; 2002 Mar; 167(3):1458-63. PubMed ID: 11832770
[TBL] [Abstract][Full Text] [Related]
11. SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
Blattner M; Liu D; Robinson BD; Huang D; Poliakov A; Gao D; Nataraj S; Deonarine LD; Augello MA; Sailer V; Ponnala L; Ittmann M; Chinnaiyan AM; Sboner A; Chen Y; Rubin MA; Barbieri CE
Cancer Cell; 2017 Mar; 31(3):436-451. PubMed ID: 28292441
[TBL] [Abstract][Full Text] [Related]
12. The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 1: Modifications to the androgen receptor.
Edwards J; Bartlett JM
BJU Int; 2005 Jun; 95(9):1320-6. PubMed ID: 15892825
[No Abstract] [Full Text] [Related]
13. The androgen receptor and mechanisms for androgen independence in prostate cancer.
Javidan J; Deitch AD; Shi XB; de Vere White RW
Cancer Invest; 2005; 23(6):520-8. PubMed ID: 16203660
[No Abstract] [Full Text] [Related]
14. The development of androgen-independent prostate cancer.
Feldman BJ; Feldman D
Nat Rev Cancer; 2001 Oct; 1(1):34-45. PubMed ID: 11900250
[TBL] [Abstract][Full Text] [Related]
15. Progress in understanding androgen-independent prostate cancer (AIPC): a review of potential endocrine-mediated mechanisms.
Schröder FH
Eur Urol; 2008 Jun; 53(6):1129-37. PubMed ID: 18262723
[TBL] [Abstract][Full Text] [Related]
16. Loss of PTEN is associated with progression to androgen independence.
Bertram J; Peacock JW; Fazli L; Mui AL; Chung SW; Cox ME; Monia B; Gleave ME; Ong CJ
Prostate; 2006 Jun; 66(9):895-902. PubMed ID: 16496415
[TBL] [Abstract][Full Text] [Related]
17. The androgen receptor: a potential target for therapy of prostate cancer.
Santos AF; Huang H; Tindall DJ
Steroids; 2004 Feb; 69(2):79-85. PubMed ID: 15013685
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor and prostate cancer: molecular aspects and gene expression profiling.
Sommer A; Haendler B
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):702-11. PubMed ID: 14579520
[TBL] [Abstract][Full Text] [Related]
19. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
[TBL] [Abstract][Full Text] [Related]
20. [The mechanism of hormone-independent recurrence of prostate cancer].
Fukabori Y
Nihon Rinsho; 2000 Jul; 58 Suppl():45-52. PubMed ID: 11022683
[No Abstract] [Full Text] [Related]
[Next] [New Search]